Product Information
EC5026 is a drug that has been shown to have anti-inflammatory properties. It was found to suppress the production of pro-inflammatory cytokines such as IL-6 and TNF-α in wild-type mice in an oral dosage form. EC5026 also inhibits the production of inflammatory mediators such as prostaglandin E2, leukotriene B4, and epoxyeicosatrienoic acids. The drug has been shown to inhibit the expression of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Inhibition of these enzymes leads to increased activation of cannabinoid receptors, which are involved in pain regulation.
EC5026 is not addictive and does not cause any changes in blood pressure or heart rate when administered orally at doses that have been shown to be effective for treatment of chronic inflammation.
Chemical properties
Technical inquiry about: 3D-JXC88532 EC5026
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
